- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04684849
Assessment and Validation of Electronic Gas and Bloating Diary
October 21, 2022 updated by: Satish Rao, Augusta University
The investigator's goal is to improve the patient's compliance and accurate capture of patient reported gas and bloating symptoms, by utilizing a phone application that interactively records each gas and bloating event in addition to bowel events and other bowel symptoms.
Such an electronic stool diary may relieve the burden of using a paper daily stool diary.
The investigator will compare and validate the electronic gas and bloating diary with the paper gas and bloating diary.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Gas-related symptoms (GRS) such as abdominal bloating, flatulence, and belching are some of the most common gastrointestinal complaints posed by the general population.
These are hallmark symptoms in patients with functional gut disorders like irritable bowel syndrome but have also been linked to conditions such as gut hypersensitivity, altered gut microbiota and altered gut motility.
The main issue with grasping the full impact of these symptoms on a patients' quality of life is that they are largely subjective and thus almost impossible to standardize.
However, given their pervasiveness there is merit attempting to gauge their severity in as objective a manner as possible in order to track disease progress and response to treatment.
GRS can be widely irregular and requiring patients to call into the office to answer questionnaires post treatment or keep handwritten logs to turn in later can lead to inaccurate data collection that can hinder accurate diagnosis and management.
The ubiquitous nature of smartphones and user-friendly interfaces of electronic applications allow for information to be logged/accessed remotely and securely, each log would have their own time stamp and be recorded in an organized, consistent manner.
Study Type
Observational
Enrollment (Anticipated)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Satish Rao, MD PhD
- Phone Number: (706) 446-4887
- Email: srao@augusta.edu
Study Contact Backup
- Name: Yun Yan, PhD
- Phone Number: 706-721-2263
- Email: yyan@augusta.edu
Study Locations
-
-
Georgia
-
Augusta, Georgia, United States, 30912
- Recruiting
- Augusta University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Anyone ages 18 to 80 years with constipation and gas and bloating symptoms.
Description
Inclusion/Exclusion for gas and bloating subjects:
Inclusion:
- Anyone 18 to 80 years of age, inclusive with gas-related symptoms (GRS) such as gas and bloating, plus any of the following: distension, diarrhea, and/ or abdominal discomfort.
- Normal upper endoscopy, normal colonoscopy (<5 years) if patient is > 50 years of age, normal computerized abdominal tomography scan, or a normal right upper quadrant scan
Exclusion:
- Women of childbearing age will be asked if they are pregnant, and a negative response will be sufficient. No pregnancy test will be performed.
- History of previous GI surgeries (except for cholecystectomy, hysterectomy, and appendectomy)
- Significant co-morbid medical conditions, including stroke, COPD( Chronic Obstructive Pulmonary Disease) and cancers (except for non-melanotic skin cancer)
- Recent hospitalization within 30 days of enrollment in this study
- Recent History (within 4 weeks) of antibiotic use
- Recent History (within one week) of a colonoscopy or barium study
Inclusion/Exclusion for healthy subjects:
Inclusion:
1. Anyone 18 to 80 years of age, inclusive with no medical problems and a negative bowel disease screening questionnaire.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Healthy subjects
Subjects who are healthy without disease
|
Subjects keep a multi- item electronic digital App survey of symptoms for 2 weeks
Subjects keep a multi-item paper survey of symptoms for 2 weeks
|
|
Gas and Bloating patients
Patients with symptoms of gas and bloating
|
Subjects keep a multi- item electronic digital App survey of symptoms for 2 weeks
Subjects keep a multi-item paper survey of symptoms for 2 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Correlation of electronic APP diary information with paper form gas and bloating diary in healthy subjects
Time Frame: 2 weeks each
|
The gas and bloating parameters recorded in the paper form gas bloating diary over 2 weeks will be correlated with the electronic APP gas and bloating diary parameters using Pearson correlation in healthy subjects
|
2 weeks each
|
|
Correlation of electronic APP diary information with paper form gas and bloating diary in gas and bloating subjects
Time Frame: 2 weeks each
|
The gas and bloating parameters recorded in the paper form gas and bloating diary over 2 weeks will be correlated with the electronic APP gas and bloating diary parameters using Pearson correlation in gas and bloating subjects
|
2 weeks each
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Flatulence (Gas)
Time Frame: 2 weeks each
|
Frequency, duration, and severity of flatulence will be compared between the APP and gas and bloating diary and between healthy subjects and patients with gas and bloating .
|
2 weeks each
|
|
Abdominal distension
Time Frame: 2 weeks each
|
Frequency, duration, and severity of abdominal distension will be compared between the APP and gas and bloating diary and between healthy subjects and patients with gas and bloating .
|
2 weeks each
|
|
Bloating
Time Frame: 2 weeks each
|
Frequency, duration, and severity of bloating will be compared between the APP and gas and bloating diary and between healthy subjects and patients with gas and bloating .
|
2 weeks each
|
|
Abdominal Pain
Time Frame: 2 weeks each
|
Frequency, duration, and severity of abdominal pain will be compared between the APP and gas and bloating diary and between healthy subjects and patients with gas and bloating.
|
2 weeks each
|
|
Belching
Time Frame: 2 weeks each
|
Frequency, duration, and severity of belching will be compared between the APP and gas and bloating diary and between healthy subjects and patients with gas and bloating.
|
2 weeks each
|
|
Indigestion
Time Frame: 2 weeks
|
Frequency, duration, and severity of indigestion will be compared between the APP and gas and bloating diary and between healthy subjects and patients with gas and bloating.
|
2 weeks
|
|
Nausea
Time Frame: 2 weeks
|
Frequency, duration, and severity of nausea will be compared between the APP and gas and bloating diary and between healthy subjects and patients with gas and bloating.
|
2 weeks
|
|
Vomiting
Time Frame: 2 weeks
|
Frequency and severity of vomiting will be compared between the APP and gas and bloating diary and between healthy subjects and patients with gas and bloating.
|
2 weeks
|
|
Number of Bowel Movements
Time Frame: 2 weeks
|
The number of Bowel Movements will be compared between the APP and gas and bloating diary and between healthy subjects and patients with gas and bloating.
|
2 weeks
|
|
Constipation
Time Frame: 2 weeks
|
Frequency, duration, and severity of constipation will be compared between the APP and gas and bloating diary and between healthy subjects and patients with gas and bloating.
|
2 weeks
|
|
Diarrhea
Time Frame: 2 weeks
|
Frequency and severity of diarrhea will be compared between the APP and gas and bloating diary and between healthy subjects and patients with gas and bloating.
|
2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Satish Rao, MD PhD, Augusta University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 10, 2020
Primary Completion (Anticipated)
December 31, 2023
Study Completion (Anticipated)
August 31, 2024
Study Registration Dates
First Submitted
November 19, 2020
First Submitted That Met QC Criteria
December 21, 2020
First Posted (Actual)
December 28, 2020
Study Record Updates
Last Update Posted (Actual)
October 24, 2022
Last Update Submitted That Met QC Criteria
October 21, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1541299
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Constipation
-
Peking Union Medical College HospitalInstitute of Process Engineering, Chinese Academy of SciencesNot yet recruitingChronic Constipation | Constipation - Functional | Fecal Microbiota TransplantationChina
-
Hamilton Health Sciences CorporationNot yet recruitingConstipation | Constipation - Functional | Constipation AggravatedCanada
-
Singapore Institute of TechnologyNot yet recruitingConstipation | Diet Modification | Constipation-predominant Irritable Bowel Syndrome | Diet Therapy | Constipation - Functional | Constipation Chronic Idiopathic | Constipation, Signs and Symptoms, Digestive | Dietary Fiber | Dietary Fibers | Constipation Predominant Irritable Bowel Syndrome | Dietary and... and other conditionsSingapore
-
Institute of Medical Sciences and SUM HospitalNot yet recruitingFunctional Constipation | Constipation - Functional | Constipation Chronic Idiopathic | Fecal Impaction | Pediatric Functional ConstipationIndia
-
Peking Union Medical College HospitalRecruitingChronic Constipation | Constipation - Functional | Fecal Microbiota Transplantation (FMT)China
-
SK Life Science, Inc.CompletedChronic Constipation | Functional ConstipationUnited States
-
Hong Kong Metropolitan UniversityNot yet recruitingConstipation | Constipation Drug Induced | Psychiatric Drug Induced ConstipationHong Kong
-
usMIMA S.L.CompletedConstipation | Constipation Chronic Idiopathic | Constipation; NeurogenicSpain, United Kingdom
-
Selin KoşanActive, not recruitingChronic Constipation | Functional Constipation | Pelvic Floor | Biofeedback | Diaphragmatic BreathingTurkey (Türkiye)
-
Hong Kong Metropolitan UniversityHospital Authority, Hong KongRecruitingConstipation | Constipation Drug Induced | Psychiatric Drug Induced ConstipationHong Kong
Clinical Trials on APP Diary
-
Augusta UniversityRecruiting
-
Scoliosis SOS Ltd.Glynn AnalyticsUnknown
-
Closed Loop MedicineCompleted
-
Riphah International UniversityCompleted
-
prof dr Pieter GillardUniversity Colleges Leuven LimburgCompleted
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...Centre for Injury Prevention and Research Bangladesh; University of Dhaka,... and other collaboratorsActive, not recruitingMental Health IssueBangladesh
-
Women's College HospitalToronto Metropolitan UniversityWithdrawnChronic Pain | Insomnia | Insomnia Due to Medical ConditionCanada
-
Region of Southern DenmarkCentral Denmark Region; University of Southern Denmark; Mclean Hospital; Innovation... and other collaboratorsUnknownBorderline Personality Disorder | Emotional Instability | Skill, CopingDenmark
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Michigan State UniversityKenyan Diabetes Management & Information Centre (DMI)CompletedType 1 DiabetesKenya